CTATTM is an innovative enzymatic linker technology for conjugating different payloads with antibodies, without affecting their specificity, binding properties or stability. In the presented xenograft trial, the tested CTAT-ADC showed superior efficacy versus a commercially available ADC.
Scope of ChitoTex is to develop and produce new insect chitosan and chitosan based functional coatings for yarns and textile fabrics. The three-year project with seven academic and industry partners is funded through the ERA-NET Scheme of the 7th EU Framework Programme.
EUCODIS is glad to announce the addition of a new enzyme family to its portfolio of recombinant industrial enzymes. Our collection of more than 20 Peroxidases is carefully selected from 10 subfamilies, and all Peroxidases display unique properties for their utility in chemical, flavor, feed, cosmetics, paper and other industries. EUCODIS Peroxidases use hydrogen peroxide as a co-substrate to catalyze reactions similar to cytochrome P450 oxidoreductases, but eliminating the need for expensive cofactor recycling systems. The enzymes are exclusively available from EUCODIS.
- INVISTA and EUCODIS Bioscience collaborate on development of enzymes for production of industrial chemicals
- CTAT: Further proof-of-concept data presented at PEGS Boston 2014
- EUCODIS successfully manufactured ferritin at industrial pilot scale for BiAqua
- Quality management system ISO9001 certificate received